Insights into immune microenvironment and therapeutic targeting in androgen-associated prostate cancer subtypes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Insights into immune microenvironment and therapeutic targeting in androgen-associated prostate cancer subtypes ; volume:14 ; number:1 ; day:4 ; month:8 ; year:2024 ; pages:1-15 ; date:12.2024
Scientific reports ; 14, Heft 1 (4.8.2024), 1-15, 12.2024
- Urheber
-
Huang, Liang
Xie, Yu
Jiang, Shusuan
Dai, Tao
Xu, Zhenzhou
Shan, Hong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-68863-0
- URN
-
urn:nbn:de:101:1-2410252127467.590627954277
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huang, Liang
- Xie, Yu
- Jiang, Shusuan
- Dai, Tao
- Xu, Zhenzhou
- Shan, Hong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
AIRE promotes androgen-independent prostate cancer by directly regulating IL-6 and modulating tumor microenvironment
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression
IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
Androgen receptor profiling predicts prostate cancer outcome
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment
The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models
Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
AIRE promotes androgen-independent prostate cancer by directly regulating IL-6 and modulating tumor microenvironment
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression
IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
Androgen receptor profiling predicts prostate cancer outcome
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment
The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models
Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
AIRE promotes androgen-independent prostate cancer by directly regulating IL-6 and modulating tumor microenvironment
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression
IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
Androgen receptor profiling predicts prostate cancer outcome
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment
The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer